Generation of purified nitric oxide from liquid N2O4 for the treatment of pulmonary hypertension in hypoxemic swine

Nitric Oxide - Biology and Chemistry

Volumn 37, Issue 1, 2014, Pages 66-72

  Lovich, Mark A ^a   Fine, David H ^b   Denton, Ryan J ^b   Wakim, Matt G ^a   Wei, Abraham E ^a   Maslov, Mikhail Y ^a   Gamero, Lucas G ^b   Vasquez, Gregory B ^b   Johnson, Bryan J ^b   Roscigno, Robert F ^b   Gilbert, Richard J ^c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GeNO LLC   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Ambulatory therapy; Dinitrogen tetraoxide; Hypoxemic swine model; Nitric oxide; Pulmonary hypertension

Indexed keywords

GAS; NITRIC OXIDE; NITROGEN DIOXIDE; NITROGEN OXIDE;

ANIMAL; ANOXIA; CHEMISTRY; COMPLICATION; GAS; HYPERTENSION, PULMONARY; ISOLATION AND PURIFICATION; OXIDATION REDUCTION REACTION; SWINE; SYNTHESIS; TEMPERATURE; THERAPEUTIC USE;

ANIMALS; ANOXIA; GASES; HYPERTENSION, PULMONARY; NITRIC OXIDE; NITROGEN OXIDES; OXIDATION-REDUCTION; SWINE; TEMPERATURE;

EID: 84894563730     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2014.02.001     Document Type: Article

References (58)

1. E. Troncy, M. Francoeur, and G. Blaise Inhaled nitric oxide: clinical applications, indications, and toxicology Can. J. Anaesth. 44 1997 973 988
2. J. Pepke-Zaba, T.W. Higenbottam, A.T. Dinh-Xuan, D. Stone, and J. Wallwork Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension Lancet 338 1991 1173 1174
3. C.G. Frostell, H. Blomqvist, G. Hedenstierna, J. Lundberg, and W.M. Zapol Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation Anesthesiology 78 1993 427 435
4. C. Frostell, M.D. Fratacci, J.C. Wain, R. Jones, and W.M. Zapol Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction Circulation 83 1991 2038 2047
5. S.H. Abman, B.A. Chatfield, S.L. Hall, and I.F. McMurtry Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth Am. J. Physiol. 259 1990 H1921 H1927
6. D.C. McCurnin, R.A. Pierce, L.Y. Chang, L.L. Gibson, S. Osborne-Lawrence, B.A. Yoder, J.D. Kerecman, K.H. Albertine, V.T. Winter, J.J. Coalson, J.D. Crapo, P.H. Grubb, and P.W. Shaul Inhaled no improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease Am. J. Physiol. Lung Cell. Mol. Physiol. 288 2005 L450 L459
7. R.D. Bland, K.H. Albertine, D.P. Carlton, and A.J. MacRitchie Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs Am. J. Respir. Crit. Care Med. 172 2005 899 906
8. V. Balasubramaniam, J.R. Tang, A. Maxey, C.G. Plopper, and S.H. Abman Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse Am. J. Physiol. Lung Cell. Mol. Physiol. 284 2003 L964 L971
9. J.D. Roberts, D.M. Polaner, P. Lang, and W.M. Zapol Inhaled nitric oxide in persistent pulmonary hypertension of the newborn Lancet 340 1992 818 819
10. R.H. Clark, T.J. Kueser, M.W. Walker, W.M. Southgate, J.L. Huckaby, J.A. Perez, B.J. Roy, M. Keszler, and J.P. Kinsella Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical inhaled nitric oxide research group N. Engl. J. Med. 342 2000 469 474
11. J.P. Kinsella, S.R. Neish, E. Shaffer, and S.H. Abman Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn Lancet 340 1992 819 820
12. R.P. Dellinger, J.L. Zimmerman, R.W. Taylor, and R.C. Straube Placebo and inhaled nitric oxide mortality the same in ards clinical trial Crit. Care Med. 26 1998 619
13. S. Lundin, H. Mang, M. Smithies, O. Stenqvist, and C. Frostell Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European study group of inhaled nitric oxide Intensive Care Med. 25 1999 911 919
14. B. Gaston, J.M. Drazen, J. Loscalzo, and J.S. Stamler The biology of nitrogen oxides in the airways Am. J. Respir. Crit. Care Med. 149 1994 538 551
15. B.E. Marshall, C.W. Hanson, F. Frasch, and C. Marshall Role of hypoxic pulmonary vasoconstriction in pulmonary gas exchange and blood flow distribution. 2. Pathophysiology Intensive Care Med. 20 1994 379 389
16. B.A. Cockrill, R.M. Kacmarek, M.A. Fifer, L.M. Bigatello, L.C. Ginns, W.M. Zapol, and M.J. Semigran Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension Chest 119 2001 128 136
17. S.G. Haworth Development of the normal and hypertensive pulmonary vasculature Exp. Physiol. 80 1995 843 853
18. M. Solc Kinetics of the reaction of nitric oxide with molecular oxygen Nature 209 1966 706
19. M.A. Clyne, and B.A. Thrush Rates of the reactions of nitrogen atoms with oxygen and with nitric oxide Nature 189 1961 56 57
20. U. Schedin, C.G. Frostell, and L.E. Gustafsson Formation of nitrogen dioxide from nitric oxide and their measurement in clinically relevant circumstances Br. J. Anaesth. 82 1999 182 192
21. M.A. Lovich, N.K. Bruno, C.P. Plant, A.E. Wei, G.B. Vasquez, B.J. Johnson, D.H. Fine, and R.J. Gilbert Use of ultra pure nitric oxide generated by the reduction of nitrogen dioxide to reverse pulmonary hypertension in hypoxemic swine Nitric Oxide 24 2011 204 212
22. H. Callen Thermodynamics and An Introduction to Thermostatistics 1985 John Wiley & Sons New York
23. G. Simonneau, R.J. Barst, N. Galie, R. Naeije, S. Rich, R.C. Bourge, A. Keogh, R. Oudiz, A. Frost, S.D. Blackburn, J.W. Crow, and L.J. Rubin Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial Am. J. Respir. Crit. Care Med. 165 2002 800 804
24. M.M. Hoeper, M. Schwarze, S. Ehlerding, A. Adler-Schuermeyer, E. Spiekerkoetter, J. Niedermeyer, M. Hamm, and H. Fabel Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue N. Engl. J. Med. 342 2000 1866 1870
25. V.V. McLaughlin, D.E. Genthner, M.M. Panella, and S. Rich Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension N. Engl. J. Med. 338 1998 273 277
26. R.J. Barst, L.J. Rubin, W.A. Long, M.D. McGoon, S. Rich, D.B. Badesch, B.M. Groves, V.F. Tapson, R.C. Bourge, B.H. Brundage, S.K. Koerner, D. Langleben, C.A. Keller, S. Murali, B.F. Uretsky, L.M. Clayton, M.M. Jobsis, S.D. Blackburn, D. Shortino, and J.W. Crow A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension N. Engl. J. Med. 334 1996 296 301
27. S.L. Archer, and E.D. Michelakis Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension N. Engl. J. Med. 361 2009 1864 1871
28. R.N. Channick, G. Simonneau, O. Sitbon, I.M. Robbins, A. Frost, V.F. Tapson, D.B. Badesch, S. Roux, M. Rainisio, F. Bodin, and L.J. Rubin Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study Lancet 358 2001 1119 1123
29. H. Krum, R.J. Viskoper, Y. Lacourciere, M. Budde, and V. Charlon The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan hypertension investigators N. Engl. J. Med. 338 1998 784 790
30. T.F. Luscher, and M. Barton Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs Circulation 102 2000 2434 2440
31. T. Wang, D. El Kebir, and G. Blaise Inhaled nitric oxide in 2003: a review of its mechanisms of action Can. J. Anaesth. 50 2003 2003 839 846
32. K.D. Bloch, F. Ichinose, J.D. Roberts, and W.M. Zapol Inhaled no as a therapeutic agent Cardiovasc. Res. 75 2007 339 348
33. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
34. R.M. Palmer, A.G. Ferrige, and S. Moncada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524 526
35. L.J. Ignarro, G.M. Buga, K.S. Wood, R.E. Byrns, and G. Chaudhuri Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide Proc. Natl. Acad. Sci. U. S. A. 84 1987 9265 9269
36. M.F. Goy Cgmp: the wayward child of the cyclic nucleotide family Trends Neurosci. 14 1991 293 299
37. J.M. Hare, and J.S. Stamler No/redox disequilibrium in the failing heart and cardiovascular system J. Clin. Invest. 115 2005 509 517
38. R. Feil, S.M. Lohmann, H. de Jonge, U. Walter, and F. Hofmann Cyclic gmp-dependent protein kinases and the cardiovascular system: insights from genetically modified mice Circ. Res. 93 2003 907 916
39. W.E. Hurford The biologic basis for inhaled nitric oxide Respir. Care Clin. N. Am. 3 1997 357 369
40. L. Xue, F. Xu, L. Meng, S. Wei, J. Wang, P. Hao, Y. Bian, Y. Zhang, and Y. Chen Acetylation-dependent regulation of mitochondrial aldh2 activation by sirt3 mediates acute ethanol-induced enos activation FEBS Lett. 586 2012 137 142
41. P. Sarti, E. Forte, A. Giuffre, D. Mastronicola, M.C. Magnifico, and M. Arese The chemical interplay between nitric oxide and mitochondrial cytochrome c oxidase: reactions, effectors and pathophysiology Int. J. Cell Biol. 2012 2012 571067
42. M. Trebak, R. Ginnan, H.A. Singer, and D. Jourd'heuil Interplay between calcium and reactive oxygen/nitrogen species: an essential paradigm for vascular smooth muscle signaling Antioxid. Redox Signal. 12 2010 657 674
43. R.W. Taylor, J.L. Zimmerman, R.P. Dellinger, R.C. Straube, G.J. Criner, K. Davis Jr., K.M. Kelly, T.C. Smith, and R.J. Small Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial JAMA 291 2004 1603 1609
44. S. Emil, S. Kanno, J. Berkeland, M. Kosi, and J. Atkinson Sustained pulmonary vasodilation after inhaled nitric oxide for hypoxic pulmonary hypertension in swine J. Pediatr. Surg. 31 1996 389 393
45. S.G. Emil, J.E. Berkeland, and J.B. Atkinson Nitric oxide dose response during moderate and severe hypoxia in swine Ann. Thorac. Surg. 63 1997 414 418
46. T.D. Jacob, D.K. Nakayama, I. Seki, R. Exler, J.R. Lancaster Jr., M.A. Sweetland, S. Yousem, R.L. Simmons, T.R. Billiar, and A.B. Peitzman et al. Hemodynamic effects and metabolic fate of inhaled nitric oxide in hypoxic piglets J. Appl. Physiol. 76 1994 1794 1801
47. M. Max, R. Kuhlen, R. Dembinski, and R. Rossaint Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension Intensive Care Med. 25 1999 1147 1154
48. M.D. Schreiber, R. Dixit, B. Rudinsky, R. Hipps, S.E. Morgan, R.A. Keith, and W. Meadow Direct comparison of the effects of nebulized nitroprusside versus inhaled nitric oxide on pulmonary and systemic hemodynamics during hypoxia-induced pulmonary hypertension in piglets Crit. Care Med. 30 2002 2560 2565
49. R.N. Channick, J.W. Newhart, F.W. Johnson, P.J. Williams, W.R. Auger, P.F. Fedullo, and K.M. Moser Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests Chest 109 1996 1545 1549
50. G. Perez-Penate, G. Julia-Serda, J.M. Pulido-Duque, E. Gorriz-Gomez, and P. Cabrera-Navarro One-year continuous inhaled nitric oxide for primary pulmonary hypertension Chest 119 2001 970 973
51. G.L. Yung, J.M. Kriett, S.W. Jamieson, F.W. Johnson, J. Newhart, K. Kinninger, and R.N. Channick Outpatient inhaled nitric oxide in a patient with idiopathic pulmonary fibrosis: a bridge to lung transplantation J. Heart Lung Transplant. 20 2001 1224 1227
52. J.C. Chang, Y. Sawa, S. Ohtake, N. Fukushima, M. Nishimura, K. Kagizaki, T. Ohata, T. Yamaguchi, and H. Matsuda Hemodynamic effect of inhaled nitric oxide in dilated cardiomyopathy patients on lvad support ASAIO J. 43 1997 M418 M421
53. J.M. Hare, S.K. Shernan, S.C. Body, E. Graydon, W.S. Colucci, and G.S. Couper Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance Circulation 95 1997 2250 2253
54. M. Argenziano, A.F. Choudhri, N. Moazami, E.A. Rose, C.R. Smith, H.R. Levin, A.J. Smerling, and M.C. Oz Randomized, double-blind trial of inhaled nitric oxide in lvad recipients with pulmonary hypertension Ann. Thorac. Surg. 65 1998 340 345
55. M.T. Gladwin, G.J. Kato, D. Weiner, O.C. Onyekwere, C. Dampier, L. Hsu, R.W. Hagar, T. Howard, R. Nuss, M.M. Okam, C.K. Tremonti, B. Berman, A. Villella, L. Krishnamurti, S. Lanzkron, O. Castro, V.R. Gordeuk, W.A. Coles, M. Peters-Lawrence, J. Nichols, M.K. Hall, M. Hildesheim, W.C. Blackwelder, J. Baldassarre, and J.F. Casella Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial JAMA 305 2011 893 902
56. C.A. Head, P. Swerdlow, W.A. McDade, R.M. Joshi, T. Ikuta, M.L. Cooper, and J.R. Eckman Beneficial effects of nitric oxide breathing in adult patients with sickle cell crisis Am. J. Hematol. 85 2010 800 802
57. G.J. Kato, M.T. Gladwin, and M.H. Steinberg Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes Blood Rev. 21 2007 37 47
58. A. Fox-Robichaud, D. Payne, S.U. Hasan, L. Ostrovsky, T. Fairhead, P. Reinhardt, and P. Kubes Inhaled no as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds J. Clin. Invest. 101 1998 2497 2505